Kenneth Anderson, MD is on the advisory board for Celgene, Gentium, Millennium, and Novartis, has received grant/research support from Celgene, Millennium, and Novartis, has received honoraria from Celgene, Millennium, and Novartis, and is on the speaker's bureau for Celgene and Millennium.
Authored Items
Recent Advances In The Treatment of Multiple Myeloma: Proceedings From a Post-EHA Roundtable
Paul Richardson, MD, Kenneth C. Anderson, MD, Jesús San Miguel, MD, Evangelos Terpos, MD, PhD
Supplements
Recent Advances In The Treatment Of Multiple Myeloma: Proceedings From a Post-ASCO Roundtable
Evangelos Terpos, MD, PhD, Jesús San Miguel, MD, Kenneth C. Anderson, MD, Paul Richardson, MD
Supplements
Recent Advances In The Treatment Of Multiple Myeloma: Proceedings From a Post-IMW Roundtable
Evangelos Terpos, MD, PhD, Jesús San Miguel, MD, Kenneth C. Anderson, MD, Paul Richardson, MD, Sergio Giralt, MD
Supplements
Recent Advances In The Treatment Of Multiple Myeloma: Proceedings From a Post-ASH Roundtable
Paul Richardson, MD, Kenneth C. Anderson, MD, William Bensinger, MD, Jesús San Miguel, MD, Evangelos Terpos, MD, PhD
Supplements
Conference Faculty Perspectives: Highlights From ASCO 2010
Paul Richardson, MD, William Bensinger, MD, Kenneth C. Anderson, MD, Melissa Alsina, MD, Jonathan Kaufman, MD
Supplements
Last modified: November 22, 2010